CBUS Stock Overview
Cibus, Inc., a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Cibus, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$17.11 |
| 52 Week High | US$38.85 |
| 52 Week Low | US$8.90 |
| Beta | 1.95 |
| 1 Month Change | -16.00% |
| 3 Month Change | -0.81% |
| 1 Year Change | -5.21% |
| 3 Year Change | -92.72% |
| 5 Year Change | -97.82% |
| Change since IPO | -96.96% |
Recent News & Updates
Recent updates
Cibus: Expanding Opportunities And Growing Accessible Market
Jan 12Is Cibus, Inc. (NASDAQ:CBUS) Trading At A 44% Discount?
Oct 19
Does Cibus (NASDAQ:CBUS) Have A Healthy Balance Sheet?
Sep 07Calyxt signs agreement with Evologic to scale production of plant-based ingredients
Oct 07Calyxt exploring strategic alternatives
Sep 22Calyxt Switches Gears Again, But The Cash Clock Keeps Ticking Down
Apr 01Calyxt Needs To Secure More Commercial Partners As Cash Dwindles
Sep 16Will Calyxt (NASDAQ:CLXT) Spend Its Cash Wisely?
Aug 17Analysts Just Shaved Their Calyxt, Inc. (NASDAQ:CLXT) Forecasts Dramatically
May 11Calyxt, Inc. 2021 Q1 - Results - Earnings Call Presentation
May 08Is Calyxt (NASDAQ:CLXT) A Risky Investment?
Apr 30Calyxt, Inc. (NASDAQ:CLXT) Analysts Just Cut Their EPS Forecasts Substantially
Mar 09Here's What Calyxt, Inc.'s (NASDAQ:CLXT) Shareholder Ownership Structure Looks Like
Feb 25Shareholder Returns
| CBUS | US Biotechs | US Market | |
|---|---|---|---|
| 7D | 12.1% | -1.5% | -0.7% |
| 1Y | -5.2% | 0.1% | 22.3% |
Return vs Industry: CBUS underperformed the US Biotechs industry which returned 0.1% over the past year.
Return vs Market: CBUS underperformed the US Market which returned 22.3% over the past year.
Price Volatility
| CBUS volatility | |
|---|---|
| CBUS Average Weekly Movement | 9.5% |
| Biotechs Industry Average Movement | 11.5% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CBUS's share price has been volatile over the past 3 months.
Volatility Over Time: CBUS's weekly volatility has decreased from 16% to 10% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 183 | Rory Riggs | www.cibus.com |
Cibus, Inc., a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. Cibus, Inc. is based in San Diego, California.
Cibus, Inc. Fundamentals Summary
| CBUS fundamental statistics | |
|---|---|
| Market cap | US$422.25m |
| Earnings (TTM) | -US$267.63m |
| Revenue (TTM) | US$1.82m |
203.6x
P/S Ratio-1.4x
P/E RatioIs CBUS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CBUS income statement (TTM) | |
|---|---|
| Revenue | US$1.82m |
| Cost of Revenue | US$0 |
| Gross Profit | US$1.82m |
| Other Expenses | US$269.44m |
| Earnings | -US$267.63m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 09, 2024
| Earnings per share (EPS) | -12.38 |
| Gross Margin | 100.00% |
| Net Profit Margin | -14,729.06% |
| Debt/Equity Ratio | 0.4% |
How did CBUS perform over the long term?
See historical performance and comparison